T1	Participants 95 128	the treatment of moderate asthma.
T2	Participants 270 293	the treatment of asthma
T3	Participants 428 507	patients with moderate asthma previously treated with an inhaled corticosteroid
T4	Participants 611 821	342 adolescent and adult patients with moderate asthma [forced expiratory volume in 1 second (FEV1) between 50% and 80% of predicted] treated previously by beclomethasone dipropionate or triamcinolone acetonide
T5	Participants 1782 1811	fluticasone propionate groups
T6	Participants 1980 2026	lung function in patients with moderate asthma
